BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21362182)

  • 1. Validation of a case definition to define chronic dialysis using outpatient administrative data.
    Clement FM; James MT; Chin R; Klarenbach SW; Manns BJ; Quinn RR; Ravani P; Tonelli M; Hemmelgarn BR;
    BMC Med Res Methodol; 2011 Mar; 11():25. PubMed ID: 21362182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the optimal case definition for the diagnosis of end-stage renal disease from administrative claims data in Manitoba, Canada.
    Komenda P; Yu N; Leung S; Bernstein K; Blanchard J; Sood M; Rigatto C; Tangri N
    CMAJ Open; 2015; 3(3):E264-9. PubMed ID: 26457290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing and validating an algorithm to identify incident chronic dialysis patients using administrative data.
    Gibertoni D; Voci C; Iommi M; D'Ercole B; Mandreoli M; Santoro A; Mancini E
    BMC Med Inform Decis Mak; 2020 Aug; 20(1):185. PubMed ID: 32782026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can dialysis patients be accurately identified using healthcare claims data?
    Taneja C; Berger A; Inglese GW; Lamerato L; Sloand JA; Wolff GG; Sheehan M; Oster G
    Perit Dial Int; 2014; 34(6):643-51. PubMed ID: 24497600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Lack of a Standardized Definition of Chronic Dialysis Treatment in German Statutory Health Insurance Claims Data.
    Bothe T; Fietz AK; Mielke N; Freitag J; Ebert N; Schaeffner E
    Dtsch Arztebl Int; 2024 Mar; 121(5):148-154. PubMed ID: 38381660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of volume overload hospitalizations among hemodialysis patients using administrative claims: a validation study.
    Assimon MM; Nguyen T; Katsanos SL; Brunelli SM; Flythe JE
    BMC Nephrol; 2016 Nov; 17(1):173. PubMed ID: 27835958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidity ascertainment from the ESRD Medical Evidence Report and Medicare claims around dialysis initiation: a comparison using US Renal Data System data.
    Krishnan M; Weinhandl ED; Jackson S; Gilbertson DT; Lacson E
    Am J Kidney Dis; 2015 Nov; 66(5):802-12. PubMed ID: 26015277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administrative data identify sickle cell disease: A critical review of approaches in U.S. health services research.
    Grosse SD; Green NS; Reeves SL
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28703. PubMed ID: 32939942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney Failure and ESRD in the Atherosclerosis Risk in Communities (ARIC) Study: Comparing Ascertainment of Treated and Untreated Kidney Failure in a Cohort Study.
    Rebholz CM; Coresh J; Ballew SH; McMahon B; Whelton SP; Selvin E; Grams ME
    Am J Kidney Dis; 2015 Aug; 66(2):231-9. PubMed ID: 25773483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study.
    Boulware LE; Tangri N; Ephraim PL; Scialla JJ; Sozio SM; Crews DC; Shafi T; Miskulin DC; Liu J; St Peter W; Jaar BG; Wu AW; Powe NR; Navaneethan SD; Bandeen-Roche K;
    BMC Nephrol; 2012 Dec; 13():167. PubMed ID: 23217181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.
    Hruskova Z; Pippias M; Stel VS; Abad-Díez JM; Benítez Sánchez M; Caskey FJ; Collart F; De Meester J; Finne P; Heaf JG; Magaz A; Palsson R; Reisæter AV; Salama AD; Segelmark M; Traynor JP; Massy ZA; Jager KJ; Tesar V
    Am J Kidney Dis; 2019 Feb; 73(2):184-193. PubMed ID: 30122544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agreement Between Administrative Database and Medical Chart Review for the Prediction of Chronic Kidney Disease G category.
    Roy L; Zappitelli M; White-Guay B; Lafrance JP; Dorais M; Perreault S
    Can J Kidney Health Dis; 2020; 7():2054358120959908. PubMed ID: 33101698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of validated methods for identifying systemic lupus erythematosus (SLE) using administrative or claims data.
    Moores KG; Sathe NA
    Vaccine; 2013 Dec; 31 Suppl 10():K62-73. PubMed ID: 24331075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reliability of administrative databases in epidemiological research: the example of end-stage renal disease requiring renal replacement therapy in patients with diabetes].
    Nordio M; Antonucci F; Feriani M; Inio A; Marchini P
    G Ital Nefrol; 2009; 26 Suppl 45():S7-11. PubMed ID: 19382087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of patients with diabetic macular edema from claims data: a validation study.
    Bearelly S; Mruthyunjaya P; Tzeng JP; Suñer IJ; Shea AM; Lee JT; Kowalski JW; Curtis LH; Schulman KA; Lee PP
    Arch Ophthalmol; 2008 Jul; 126(7):986-9. PubMed ID: 18625948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Outcomes After TKA: Do All Databases Produce Similar Findings?
    Bedard NA; Pugely AJ; McHugh M; Lux N; Otero JE; Bozic KJ; Gao Y; Callaghan JJ
    Clin Orthop Relat Res; 2018 Jan; 476(1):52-63. PubMed ID: 29529616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficiary characteristics and vaccinations in the end-stage renal disease Medicare beneficiary population, an analysis of claims data 2006-2015.
    Shen AK; Kelman JA; Warnock R; Zhang W; Brereton S; McKean S; Wernecke M; Chu S; Gellin BG
    Vaccine; 2017 Dec; 35(52):7302-7308. PubMed ID: 29132990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of an algorithm for the identification of breast cancer deaths in German health insurance claims data: a validation study based on a record linkage with administrative mortality data.
    Langner I; Ohlmeier C; Haug U; Hense HW; Czwikla J; Zeeb H
    BMJ Open; 2019 Jul; 9(7):e026834. PubMed ID: 31350240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of insurance status on use of recombinant erythropoietin therapy among end-stage renal disease patients in three states.
    Thamer M; Richard C; Ray NF; Greer JW; Cotter DJ; Pearson BC
    Am J Kidney Dis; 1996 Aug; 28(2):235-49. PubMed ID: 8768919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appendix to dialysis centre guidelines: recommendations for the relationship between outpatient haemodialysis centres and reference hospitals. Opinions from the Outpatient Dialysis Group. Grupo de Trabajo de Hemodiálisis Extrahospitalaria.
    Berdud I; Arenas MD; Bernat A; Ramos R; Blanco A;
    Nefrologia; 2011; 31(6):664-9. PubMed ID: 22130281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.